The behavioural, cardiovascular and respiratory actions of morphine-N-oxide in the dog.
D000166:Acridines / Q000494:pharmacology; D000818:Animals; D001143:Arousal / Q000187:drug effects; D001285:Atropine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002339:Carotid Arteries / Q000187:drug effects; D003497:Cyclic N-Oxides / Q000494:pharmacology; D004285:Dogs; D006339:Heart Rate / Q000187:drug effects; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D009019:Morphinans / Q000008:administration & dosage / Q000494:pharmacology*; D009020:Morphine / Q000008:administration & dosage / Q000494:pharmacology*; D009269:Nalorphine / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects*; D013844:Thiazoles / Q000494:pharmacology
D000166:Acridines; D003497:Cyclic N-Oxides; D006634:Histamine H1 Antagonists; D009019:Morphinans; D011725:Pyridines; D013844:Thiazoles; D009020:Morphine; D001285:Atropine; D009269:Nalorphine